Rayca Precision

We’re aspiring towards a precise analysis of the molecular characteristics of a patient together with their specific tumor and cancer affliction in this instance. We are currently developing an AI based precision oncology platform that increases survival rate of cancer patients by providing oncologists with data driven decision making support. Rayca utilize high-throughput patient genomic data to identify the molecular pathways of cancer diseases to identify tumor behaviors in very early stages and assist clinical decision making.